250 related articles for article (PubMed ID: 16517577)
1. Lung function decline and outcomes in an elderly population.
Mannino DM; Davis KJ
Thorax; 2006 Jun; 61(6):472-7. PubMed ID: 16517577
[TBL] [Abstract][Full Text] [Related]
2. Lung function decline and outcomes in an adult population.
Mannino DM; Reichert MM; Davis KJ
Am J Respir Crit Care Med; 2006 May; 173(9):985-90. PubMed ID: 16439715
[TBL] [Abstract][Full Text] [Related]
3. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.
Mannino DM; Davis KJ; Kiri VA
Respir Med; 2009 Feb; 103(2):224-9. PubMed ID: 18945605
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?
Mannino DM; Sonia Buist A; Vollmer WM
Thorax; 2007 Mar; 62(3):237-41. PubMed ID: 17090573
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.
Prats E; Tejero E; Pardo P; Gavilán A; Galera R; Donado JR; Racionero MÁ; Casitas R; Zapatero A; García-Río F
PLoS One; 2015; 10(10):e0140855. PubMed ID: 26489023
[TBL] [Abstract][Full Text] [Related]
6. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
7. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.
Johnston AK; Mannino DM; Hagan GW; Davis KJ; Kiri VA
Thorax; 2008 Jul; 63(7):599-605. PubMed ID: 18245145
[TBL] [Abstract][Full Text] [Related]
8. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
9. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly.
Scarlata S; Pedone C; Fimognari FL; Bellia V; Forastiere F; Incalzi RA
Respir Med; 2008 Sep; 102(9):1349-54. PubMed ID: 18599282
[TBL] [Abstract][Full Text] [Related]
10. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
11. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
Thomsen M; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
[TBL] [Abstract][Full Text] [Related]
13. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
Mohamed Hoesein FA; Zanen P; Lammers JW
Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
[TBL] [Abstract][Full Text] [Related]
14. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
[TBL] [Abstract][Full Text] [Related]
15. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
16. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
17. Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study.
Engström G; Segelstorm N; Ekberg-Aronsson M; Nilsson PM; Lindgärde F; Löfdahl CG
Thorax; 2009 Mar; 64(3):211-5. PubMed ID: 18988660
[TBL] [Abstract][Full Text] [Related]
18. Association between all-cause and cause-specific mortality and the GOLD stages 1-4: A 30-year follow-up among Finnish adults.
Mattila T; Vasankari T; Kanervisto M; Laitinen T; Impivaara O; Rissanen H; Knekt P; Jousilahti P; Saarelainen S; Puukka P; Heliövaara M
Respir Med; 2015 Aug; 109(8):1012-8. PubMed ID: 26108990
[TBL] [Abstract][Full Text] [Related]
19. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
20. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
Tantucci C; Donati P; Nicosia F; Bertella E; Redolfi S; De Vecchi M; Corda L; Grassi V; Zulli R
Respir Med; 2008 Apr; 102(4):613-9. PubMed ID: 18083020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
